UCB SA Valuation
UCBJY Stock | USD 58.22 1.22 2.14% |
At this time, the entity appears to be undervalued. UCB SA ADR owns a latest Real Value of $64.39 per share. The recent price of the entity is $58.22. Our model measures the value of UCB SA ADR from evaluating the entity fundamentals such as Price To Earning of 17.55 X, return on asset of 0.0468, and Profit Margin of 0.15 % as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued equities and dropping overvalued equities since, in the future, asset prices and their ongoing real values will merge together.
Undervalued
Today
Please note that UCB SA's price fluctuation is very steady at this time. Calculation of the real value of UCB SA ADR is based on 3 months time horizon. Increasing UCB SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for UCB SA ADR is useful when determining the fair value of the UCB pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of UCB SA. Since UCB SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of UCB Pink Sheet. However, UCB SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 58.22 | Real 64.39 | Hype 58.22 | Naive 55.6 |
The real value of a stock, also known as the intrinsic value, is the underlying worth of a company that is reflected in its stock price. It is based on the company's financial performance, assets, liabilities, growth prospects, management team, industry conditions, and other relevant factors. The real value of a stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, price-to-book ratio, and other valuation metrics. The real value of a stock may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence the stock's price. It is important to note that the real value of a stock is not a fixed number and may change over time based on changes in the company's performance and other relevant factors.
Estimating the potential upside or downside of UCB SA ADR helps investors to forecast how UCB pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of UCB SA more accurately as focusing exclusively on UCB SA's fundamentals will not take into account other important factors: UCB SA Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining UCB SA's current stock value. Our valuation model uses many indicators to compare UCB SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UCB SA competition to find correlations between indicators driving UCB SA's intrinsic value. More Info.UCB SA ADR is rated first in beta category among related companies. It is rated first in net asset category among related companies making up about 41,428,571,429 of Net Asset per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value UCB SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for UCB SA's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UCB SA's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates UCB SA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in UCB SA and how it compares across the competition.
About UCB SA Valuation
The pink sheet valuation mechanism determines the current worth of UCB SA ADR on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of UCB SA ADR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of UCB SA ADR based exclusively on its fundamental and basic technical indicators. By analyzing UCB SA's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of UCB SA's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of UCB SA. We calculate exposure to UCB SA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to UCB SA's related companies.UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.
8 Steps to conduct UCB SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates UCB SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct UCB SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain UCB SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine UCB SA's revenue streams: Identify UCB SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research UCB SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish UCB SA's growth potential: Evaluate UCB SA's management, business model, and growth potential.
- Determine UCB SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate UCB SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of UCB SA represents a small ownership stake in the entity. As a stockholder of UCB, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
UCB SA Dividends Analysis For Valuation
Please note that UCB SA has scaled down on payment of dividends at this time.
There are various types of dividends UCB SA can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of UCB shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from UCB SA ADR directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When UCB pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of UCB SA by the value of the dividends paid out.
UCB SA Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as UCB SA does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 194.2 M | |
Quarterly Earnings Growth Y O Y | -0.303 | |
Forward Price Earnings | 17.5439 | |
Retained Earnings | 6.3 B |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA ADR. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for UCB Pink Sheet analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |